Riboflavin (vitamin B2) for the prevention of migraine
Por:
Expósito J.A., Bonfill Cosp X., Reveiz L., Vera Benavides L.A.
Publicada:
1 ene 2014
Resumen:
This is the protocol for a review and there is no abstract. The objectives are as follows: The objective of this review will be to describe and assess the evidence from randomised controlled trials on the efficacy and safety of riboflavin for preventing migraine in adult patients. © 2014 The Cochrane Collaboration.
Filiaciones:
Expósito J.A.:
Catalan Agency for Health Information, Assessment and Quality (CAHIAQ), Roc Boronat, 81-95, Barcelona, Catalonia, 08805, Spain
Bonfill Cosp X.:
CIBER Epidemiología y Salud Pública (CIBERESP), Universitat Autònoma de Barcelona, Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Antoni Maria Claret, 167, Pavilion 18 (D-13), Barcelona, Catalonia, 08025, Spain
Reveiz L.:
Health Systems Based on Primary Health Care (HSS), Pan American Health Organization, Research Promotion and Development Team, 525, 23rd St, NW, Washington, DC 20037-2895, United States
Vera Benavides L.A.:
Universidad Austral de Chile, Escuela de Medicina-Facultad de Medicina, Independencia 641, Casilla 567, Valdivia, 5110566, Chile
|